BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9141426)

  • 21. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells.
    Buelens C; Willems F; Delvaux A; Piérard G; Delville JP; Velu T; Goldman M
    Eur J Immunol; 1995 Sep; 25(9):2668-72. PubMed ID: 7589143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
    Biburger M; Weth R; Wels WS
    J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells.
    Rattis FM; Péguet-Navarro J; Staquet MJ; Dezutter-Dambuyant C; Courtellemont P; Redziniak G; Schmitt D
    Eur J Immunol; 1996 Feb; 26(2):449-53. PubMed ID: 8617317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B7-1 induces immunosuppression when expressed in cultured neonatal mice keratinocytes.
    Nengwen K; Li F; Li X; Juan S; Jianjun L; Chuntao Z; Youping L
    Immunobiology; 2009; 214(8):653-63. PubMed ID: 19249124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity.
    Smythe JA; Fink PD; Logan GJ; Lees J; Rowe PB; Alexander IE
    J Immunol; 1999 Sep; 163(6):3239-49. PubMed ID: 10477593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human Langerhans cells.
    Weiss JM; Renkl AC; Denfeld RW; de Roche R; Spitzlei M; Schöpf E; Simon JC
    Eur J Immunol; 1995 Oct; 25(10):2858-62. PubMed ID: 7589083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response.
    Wendtner CM; Nolte A; Mangold E; Buhmann R; Maass G; Chiorini JA; Winnacker EL; Emmerich B; Kotin RM; Hallek M
    Gene Ther; 1997 Jul; 4(7):726-35. PubMed ID: 9282174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor.
    Chan AK; Goedegebuure PS; von Bernstorff W; Carritte AL; Chung M; Stewart RA; Montgomery L; Spanjaard RA; McKenzie AB; Eberlein TJ
    Surgery; 2000 Mar; 127(3):342-50. PubMed ID: 10715992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B7.1 on human carcinomas: costimulation of T cells and enhanced tumor-induced T-cell death.
    Lang S; Atarashi Y; Nishioka Y; Stanson J; Meidenbauer N; Whiteside TL
    Cell Immunol; 2000 May; 201(2):132-43. PubMed ID: 10831322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties.
    Ferlazzo G; Semino C; Meta M; Procopio F; Morandi B; Melioli G
    Eur J Immunol; 2002 Nov; 32(11):3092-101. PubMed ID: 12385029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias.
    Costello RT; Mallet F; Chambost H; Sainty D; Gastaut JA; Olive D
    Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway.
    Ou D; Wang X; Metzger DL; Ao Z; Pozzilli P; James RF; Chen L; Warnock GL
    Cell Transplant; 2006; 15(5):399-410. PubMed ID: 16970282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of the B7-2 molecule for low dose melphalan-induced acquisition of tumor-eradicating immunity by mice bearing a large MOPC-315 tumor.
    Mokyr MB; Kalinichenko TV; Gorelik L; Bluestone JA
    J Immunol; 1998 Feb; 160(4):1866-74. PubMed ID: 9469448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triggering of murine NK cells by CD40 and CD86 (B7-2).
    Martín-Fontecha A; Assarsson E; Carbone E; Kärre K; Ljunggren HG
    J Immunol; 1999 May; 162(10):5910-6. PubMed ID: 10229827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
    Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
    Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
    Foreman KE; Wrone-Smith T; Krueger AE; Nickoloff BJ
    Clin Immunol; 1999 Jun; 91(3):345-53. PubMed ID: 10370381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The heterogeneous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon.
    Tsukada N; Aoki S; Maruyama S; Kishi K; Takahashi M; Aizawa Y
    J Exp Clin Cancer Res; 1997 Jun; 16(2):171-6. PubMed ID: 9261743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
    Wong CK; Lit LC; Tam LS; Li EK; Lam CW
    Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.